Wenpeng M. Huang

No. 1, East Jianshe Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Nectin4-targeted molecular imaging in solid tumors: Current status and future perspectives.

Nectin4-targeted molecular imaging in solid tumors: Current status and future perspectives.

Journal: View (Beijing, China)

Published: May 18, 2026

PSMA PET-directed radiotherapy for prostate cancer: From precision planning to future innovations.

PSMA PET-directed radiotherapy for prostate cancer: From precision planning to future innovations.

Journal: View (Beijing, China)

Published: March 30, 2026

A zirconium-89-labeled antibody-drug conjugate PET probe for noninvasive monitoring of Nectin4 expression in breast cancer and lung cancer.

A zirconium-89-labeled antibody-drug conjugate PET probe for noninvasive monitoring of Nectin4 expression in breast cancer and lung cancer.

Journal: Cell reports. Physical science

Published: January 19, 2026

Synchronous PET/MR imaging and visualizing penetration of nanomedicine within tumor based on 68Ga-NaGdF4 probes.

Synchronous PET/MR imaging and visualizing penetration of nanomedicine within tumor based on 68Ga-NaGdF4 probes.

Journal: Journal of nanobiotechnology

Published: December 07, 2025

Noninvasive Evaluation of Trop2 Expression Using 64Cu-NOTA-Trodelvy-F(ab')2 in Gastric and Pancreatic Cancer.

Noninvasive Evaluation of Trop2 Expression Using 64Cu-NOTA-Trodelvy-F(ab')2 in Gastric and Pancreatic Cancer.

Journal: Molecular pharmaceutics

Published: November 07, 2025

Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions.

Stimuli-responsive nanomaterials for targeted drug delivery in inflammatory bowel disease: Advances and emerging directions.

Journal: Matter

Published: November 07, 2025

Targeting Claudin18.2 for cancer theranostics: From molecular imaging to precision therapy.

Targeting Claudin18.2 for cancer theranostics: From molecular imaging to precision therapy.

Journal: iScience

Published: September 29, 2025

Noninvasive ImmunoPET imaging of PD-L1 expression in non-small cell lung cancer and bladder cancer using [89Zr]Zr-DFO-Durvalumab.

Noninvasive ImmunoPET imaging of PD-L1 expression in non-small cell lung cancer and bladder cancer using [89Zr]Zr-DFO-Durvalumab.

Journal: Colloids and surfaces. A, Physicochemical and engineering aspects

Published: September 08, 2025

An inflammation-responsive therapeutic gel for precise microbiota modulation in colitis.

An inflammation-responsive therapeutic gel for precise microbiota modulation in colitis.

Journal: Journal of nanobiotechnology

Published: August 03, 2025

Application of smart responsive nanomaterials in the theranostics of gastrointestinal malignancies: Current status and future perspectives.

Application of smart responsive nanomaterials in the theranostics of gastrointestinal malignancies: Current status and future perspectives.

Journal: Coordination chemistry reviews

Published: July 14, 2025

Development and Preclinical Validation of a Novel 89Zr-Labeled BCMA-Targeting Antibody for ImmunoPET Imaging: Application in Multiple Myeloma Models and First-In-Nonhuman-Primates.

Development and Preclinical Validation of a Novel 89Zr-Labeled BCMA-Targeting Antibody for ImmunoPET Imaging: Application in Multiple Myeloma Models and First-In-Nonhuman-Primates.

Journal: Journal of medicinal chemistry

Published: June 25, 2025

ImmunoPET Imaging of Nectin4 Expression in Gastric and Bladder Cancer Using [64Cu]Cu-NOTA-Padcev.

ImmunoPET Imaging of Nectin4 Expression in Gastric and Bladder Cancer Using [64Cu]Cu-NOTA-Padcev.

Journal: Molecular pharmaceutics

Published: May 08, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026